Since October 2023, Brazil has recorded the largest nationwide dengue fever outbreak in its history.
Almost all federal states are affected and a state of emergency has been declared in several regions.
The British daily newspaper "Financial Times" reported on June 2, 2024 that 5.5 million infections have been registered so far.
Dengue, which can cause high fever, muscle pain and internal bleeding, has already caused more than 3,200 deaths this year.
As has been known for years, in various countries around the world and in Brazil in particular, modified mosquitoes are
being released in the laboratory to combat infectious diseases.
The United Nations World Mosquito Program announced last year that it would release billions of farmed mosquitoes
in various locations in Brazil over the next ten years.
In the research method used, Asian tiger mosquitoes are infected with the naturally occurring Wolbachia
bacterium and released into a native mosquito population.
The Wolbachia bacterium is intended to prevent dengue, Zika and other viruses from being transmitted by mosquitoes to other
mosquitoes and consequently to the surrounding human population.
The Brazilian health authorities have already tested the release of laboratory mosquitoes in five large cities in Brazil.
But what were the consequences of this release?
At the very least, the current figures clearly show that there has been no reduction in the number of
dengue fever cases, but rather a record increase.
A look at the past shows that previous research projects to contain infectious diseases caused by
genetically modified mosquitoes have not been effective.
For example, the British biotechnology company Oxitec released more than twelve million genetically
modified mosquitoes in Brazil between 2013 and 2015.
The aim of this field trial at the time was to contain the population of the tiger mosquito "Aedes aegypti", which is
particularly responsible for the transmission of dengue fever.
But 30 months later, up to 60 % of the local mosquitoes were also found to have genetic changes.
But not only that, the targeted and initially achieved reduction in the tiger mosquito population
has returned to its previous level after 18 months.
A cross between the natural mosquito and the genetically modified mosquito was created, resulting in a more
robust population of mosquitoes than before the release.
Research results have also shown that the mosquitoes are equally carriers of infectious diseases before and after the experiment.
Although the previous experiments have completely failed to achieve their goal, production in the
mosquito factories in Brazil has not been stopped.
The question therefore arises as to what interests are behind the research projects and who is funding their implementation?
Back in 2019, the World Mosquito Program published on its website that the Bill & Melinda Gates Foundation and the
Wellcome Trust were supporting the research project into the Wolbachia bacterium with 50 million dollars.
The Bill & Melinda Gates Foundation funded research into the dengue vaccine back in 2003.
The vaccine is produced by the Japanese pharmaceutical company Takeda, which has also received
tens of millions of euros from the Gates Foundation.
But not only Bill Gates, other organizations also support research projects involving insects modified in the laboratory.
For example, the organization Management Sciences for Health was already working on a study in 2022 to find out
what countries around the world would be willing to pay to use the novel pathogen called Wolbachia.
According to its own information, Management Sciences for Health is supported by various
organizations, universities and private companies.
Among others by: the Bill & Melinda Gates Foundation the pharmaceutical and biotechnology company Pfizer the Asian
pharmaceutical company Takeda, which manufactures vaccines to combat dengue the global health
initiative Unitaid and the World Health Organization
A look at the Brazilian scientific institution Oswaldo Cruz Foundation (FIOCRUZ for short), which promotes mosquito
production, also reveals an astonishing network of relationships with various organizations and universities.
The following should be emphasized: the World Bank the United Nations the United Nations Children's
Fund, UNICEF for short the World Health Organization
As a look at Brazil shows, the research projects involving mosquitoes modified in the laboratory have not been discontinued,
although it is known that they fail to achieve their goal.
Despite a lack of success and no discernible reduction in infectious diseases, billions more mosquitoes
are being released, resulting in massive financing costs and an increase in illnesses and deaths.
What is behind this economic model?
Are mosquitoes to be used as a weapon of war against humanity in the future?
One conclusion remains: People in the countries where the mosquitoes are released are massively harmed.
Back in July 2023, Kla.TV founder Ivo Sasek warned of the increasing global release of genetically modified mosquitoes.
Due to the current events in Brazil, Kla.TV is broadcasting his speech again.
Here are some astonishing facts, but also the first surprising ways out.